CryoPort (CYRX) Competitors $7.58 -0.01 (-0.20%) As of 12:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CYRX vs. JANX, BHVN, ANIP, MESO, EWTX, TVTX, CVAC, PAHC, ABCL, and CALTShould you be buying CryoPort stock or one of its competitors? The main competitors of CryoPort include Janux Therapeutics (JANX), Biohaven (BHVN), ANI Pharmaceuticals (ANIP), Mesoblast (MESO), Edgewise Therapeutics (EWTX), Travere Therapeutics (TVTX), CureVac (CVAC), Phibro Animal Health (PAHC), AbCellera Biologics (ABCL), and Calliditas Therapeutics AB (publ) (CALT). These companies are all part of the "pharmaceutical products" industry. CryoPort vs. Its Competitors Janux Therapeutics Biohaven ANI Pharmaceuticals Mesoblast Edgewise Therapeutics Travere Therapeutics CureVac Phibro Animal Health AbCellera Biologics Calliditas Therapeutics AB (publ) CryoPort (NASDAQ:CYRX) and Janux Therapeutics (NASDAQ:JANX) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability. Is CYRX or JANX more profitable? Janux Therapeutics has a net margin of 0.00% compared to CryoPort's net margin of -50.15%. Janux Therapeutics' return on equity of -9.29% beat CryoPort's return on equity.Company Net Margins Return on Equity Return on Assets CryoPort-50.15% -11.03% -5.54% Janux Therapeutics N/A -9.29%-8.89% Which has higher valuation and earnings, CYRX or JANX? Janux Therapeutics has lower revenue, but higher earnings than CryoPort. Janux Therapeutics is trading at a lower price-to-earnings ratio than CryoPort, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoPort$232.13M1.64-$114.76M-$2.34-3.24Janux Therapeutics$10.59M140.20-$68.99M-$1.36-18.45 Which has more volatility and risk, CYRX or JANX? CryoPort has a beta of 1.89, suggesting that its share price is 89% more volatile than the S&P 500. Comparatively, Janux Therapeutics has a beta of 2.86, suggesting that its share price is 186% more volatile than the S&P 500. Do analysts recommend CYRX or JANX? CryoPort currently has a consensus target price of $10.88, suggesting a potential upside of 43.28%. Janux Therapeutics has a consensus target price of $95.25, suggesting a potential upside of 279.60%. Given Janux Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Janux Therapeutics is more favorable than CryoPort.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CryoPort 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Janux Therapeutics 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.09 Do institutionals & insiders have more ownership in CYRX or JANX? 92.9% of CryoPort shares are owned by institutional investors. Comparatively, 75.4% of Janux Therapeutics shares are owned by institutional investors. 10.1% of CryoPort shares are owned by company insiders. Comparatively, 29.4% of Janux Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor CYRX or JANX? In the previous week, CryoPort had 6 more articles in the media than Janux Therapeutics. MarketBeat recorded 6 mentions for CryoPort and 0 mentions for Janux Therapeutics. CryoPort's average media sentiment score of 0.05 beat Janux Therapeutics' score of 0.00 indicating that CryoPort is being referred to more favorably in the media. Company Overall Sentiment CryoPort Neutral Janux Therapeutics Neutral SummaryJanux Therapeutics beats CryoPort on 11 of the 17 factors compared between the two stocks. Get CryoPort News Delivered to You Automatically Sign up to receive the latest news and ratings for CYRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CYRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CYRX vs. The Competition Export to ExcelMetricCryoPortTRANS IndustryTransportation SectorNASDAQ ExchangeMarket Cap$378.23M$5.78B$7.18B$8.98BDividend YieldN/A2.30%914.35%4.04%P/E Ratio-3.2210.6412.8920.16Price / Sales1.641.21347.83124.91Price / CashN/A10.767.4757.86Price / Book1.022.962.115.57Net Income-$114.76M$189.74M$563.51M$248.52M7 Day Performance1.95%-1.72%0.47%5.05%1 Month Performance8.98%1.11%4.24%6.98%1 Year Performance26.42%-0.74%5.42%21.36% CryoPort Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CYRXCryoPort2.469 of 5 stars$7.59-0.1%$10.88+43.3%+19.7%$378.23M$232.13M-3.221,186Analyst ForecastJANXJanux Therapeutics2.0586 of 5 stars$23.96-2.0%$95.25+297.5%-38.0%$1.42B$10.59M-17.6230BHVNBiohaven3.1907 of 5 stars$13.81-5.6%$58.46+323.3%-59.7%$1.41BN/A-1.48239ANIPANI Pharmaceuticals3.4101 of 5 stars$64.91-0.6%$80.13+23.4%+4.3%$1.41B$614.38M-51.11600MESOMesoblast1.9853 of 5 stars$10.53-1.4%$18.00+70.9%+35.2%$1.35B$5.90M0.0080EWTXEdgewise Therapeutics2.6375 of 5 stars$12.61-3.2%$40.00+217.2%-37.8%$1.33BN/A-8.1460TVTXTravere Therapeutics3.3292 of 5 stars$14.60-2.7%$32.14+120.2%+75.5%$1.30B$273.53M-5.20460Gap UpCVACCureVac4.5018 of 5 stars$5.41-0.7%$6.83+26.3%+73.2%$1.21B$523.70M5.88880PAHCPhibro Animal Health3.6777 of 5 stars$29.90+6.8%$24.40-18.4%+71.9%$1.21B$1.02B38.331,940News CoverageAnalyst UpgradeHigh Trading VolumeABCLAbCellera Biologics2.5525 of 5 stars$4.03+6.1%$7.50+86.1%+41.5%$1.20B$28.83M-7.20500News CoverageAnalyst ForecastAnalyst RevisionGap UpHigh Trading VolumeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180 Related Companies and Tools Related Companies Janux Therapeutics Competitors Biohaven Competitors ANI Pharmaceuticals Competitors Mesoblast Competitors Edgewise Therapeutics Competitors Travere Therapeutics Competitors CureVac Competitors Phibro Animal Health Competitors AbCellera Biologics Competitors Calliditas Therapeutics AB (publ) Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CYRX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CryoPort, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CryoPort With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYRX Stock Alerts